Literature DB >> 25323316

Placebo treatments, informed consent and 'the grip of a false picture'.

Shane Nicholas Glackin.   

Abstract

It is widely supposed that the prescription of placebo treatments to patients for therapeutic purposes is ethically problematic on the grounds that the patient cannot give informed consent to the treatment, and is therefore deceived by the physician. This claim, I argue, rests on two confusions: one concerning the meaning of 'informed consent' and its relation to the information available to the patient, and another concerning the relation of body and mind. Taken together, these errors lead naturally to the conclusion that the prescription of placebos to unwitting patients is unethical. Once they are dispelled, I argue, we can see that providing 'full' information against a background of metaphysical confusion may make a patient less informed and that the 'therapeutic' goal of relieving the patient of such confusions is properly the duty of the philosopher rather than the physician. Therapeutic placebos therefore do not violate the patient's informed consent or the ethical duties of the doctor. Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.

Entities:  

Keywords:  Autonomy; Informed Consent; Philosophical Ethics; Philosophy of Medicine; Truth Disclosure

Mesh:

Substances:

Year:  2014        PMID: 25323316     DOI: 10.1136/medethics-2014-102332

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  3 in total

1.  Psychotherapy, placebos, and informed consent.

Authors:  Garson Leder
Journal:  J Med Ethics       Date:  2020-08-20       Impact factor: 2.903

2.  Lay People's Ethical Attitudes To Placebo Treatment: A Q-Methodology Study.

Authors:  Muhammad M Hammami; Safa Hammami; Reem Aboushaar; Ahmed S Aljomah
Journal:  Patient Prefer Adherence       Date:  2019-09-27       Impact factor: 2.711

3.  [Informed consent process in clinical trials: Insights of researchers, patients and general practitioners].

Authors:  Nuria Giménez; David Pedrazas; Susana Redondo; Salvador Quintana
Journal:  Aten Primaria       Date:  2016-01-14       Impact factor: 1.137

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.